These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25210455)

  • 21. Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients.
    Brendel M; Pogarell O; Xiong G; Delker A; Bartenstein P; Rominger A;
    Eur J Nucl Med Mol Imaging; 2015 Apr; 42(5):716-24. PubMed ID: 25631614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels and mutual correlations of amyloid β in patients with depression.
    Yasuda S; Baba H; Maeshima H; Shimano T; Inoue M; Ichikawa T; Shukuzawa H; Suzuki T; Arai H
    Geriatr Gerontol Int; 2020 Feb; 20(2):125-129. PubMed ID: 31833164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in the Expression of Amyloid Precursor Protein Cleaving Enzymes mRNA in Alzheimer Peripheral Blood.
    Wongchitrat P; Pakpian N; Kitidee K; Phopin K; Dharmasaroja PA; Govitrapong P
    Curr Alzheimer Res; 2019; 16(1):29-38. PubMed ID: 30411686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-sectional association between serum concentrations of n-3 long-chain PUFA and depressive symptoms: results in Japanese community dwellers.
    Horikawa C; Otsuka R; Kato Y; Nishita Y; Tange C; Kakutani S; Rogi T; Kawashima H; Shibata H; Ando F; Shimokata H
    Br J Nutr; 2016 Feb; 115(4):672-80. PubMed ID: 26689657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.
    Perin S; Harrington KD; Lim YY; Ellis K; Ames D; Pietrzak RH; Schembri A; Rainey-Smith S; Salvado O; Laws SM; Martins RN; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    J Affect Disord; 2018 Mar; 229():269-274. PubMed ID: 29329059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cerebrospinal fluid levels of amyloid precursor protein and amyloid beta-peptide in Alzheimer's disease and major depression - inverse correlation with dementia severity.
    Hock C; Golombowski S; Müller-Spahn F; Naser W; Beyreuther K; Mönning U; Schenk D; Vigo-Pelfrey C; Bush AM; Moir R; Tanzi RE; Growdon JH; Nitsch RM
    Eur Neurol; 1998; 39(2):111-8. PubMed ID: 9520072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive impairment and depressive symptoms lead to biases in self-evaluated masticatory performance among community-dwelling older Japanese adults: the Tsurugaya Project.
    Komiyama T; Ohi T; Hiratsuka T; Miyoshi Y; Tomata Y; Zhang S; Tsuji I; Watanabe M; Hattori Y
    J Dent; 2020 Aug; 99():103403. PubMed ID: 32522688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
    Futamura A; Hieda S; Mori Y; Kasuga K; Sugimoto A; Kasai H; Kuroda T; Yano S; Tsuji M; Ikeuchi T; Irie K; Ono K
    J Alzheimers Dis; 2021; 80(2):639-646. PubMed ID: 33579852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do depressive symptoms predict Alzheimer's disease and dementia?
    Gatz JL; Tyas SL; St John P; Montgomery P
    J Gerontol A Biol Sci Med Sci; 2005 Jun; 60(6):744-7. PubMed ID: 15983177
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of the association between cognitive impairment and the vitamin D levels among community-dwelling Japanese pre-frail elderly individuals].
    Okuno J; Fukasaku T; Hotta K; Yabushita N; Pei L; Okura T; Tanaka K; Yanagi H
    Nihon Ronen Igakkai Zasshi; 2013; 50(4):515-21. PubMed ID: 24047667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic Intra Oral Pain and Depressive Symptoms in Japanese Community-Dwelling Elderly: A Longitudinal Study.
    Hanindriyo L; Yoshihara A; Takiguchi T; Miyazaki H
    Community Dent Health; 2018 May; 35(2):102-108. PubMed ID: 29664579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Cognitive Function with Amyloid-β and Tau Proteins in the Vitreous Humor.
    Wright LM; Stein TD; Jun G; Chung J; McConnell K; Fiorello M; Siegel N; Ness S; Xia W; Turner KL; Subramanian ML
    J Alzheimers Dis; 2019; 68(4):1429-1438. PubMed ID: 30856114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans.
    Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH
    Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of chewing ability and its relationship with activities of daily living, depression, cognitive status and food intake in the community-dwelling elderly.
    Kimura Y; Ogawa H; Yoshihara A; Yamaga T; Takiguchi T; Wada T; Sakamoto R; Ishimoto Y; Fukutomi E; Chen W; Fujisawa M; Okumiya K; Otsuka K; Miyazaki H; Matsubayashi K
    Geriatr Gerontol Int; 2013 Jul; 13(3):718-25. PubMed ID: 23279752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical Amyloid β Deposition and Current Depressive Symptoms in Alzheimer Disease and Mild Cognitive Impairment.
    Chung JK; Plitman E; Nakajima S; Chakravarty MM; Caravaggio F; Gerretsen P; Iwata Y; Graff-Guerrero A;
    J Geriatr Psychiatry Neurol; 2016 May; 29(3):149-59. PubMed ID: 26400248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease.
    Schupf N; Tang MX; Fukuyama H; Manly J; Andrews H; Mehta P; Ravetch J; Mayeux R
    Proc Natl Acad Sci U S A; 2008 Sep; 105(37):14052-7. PubMed ID: 18779561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High amyloid-β deposition related to depressive symptoms in older individuals with normal cognition: a pilot study.
    Yasuno F; Kazui H; Morita N; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Matsuoka K; Kosaka J; Kudo T; Iida H; Kishimoto T; Nagatsuka K
    Int J Geriatr Psychiatry; 2016 Aug; 31(8):920-8. PubMed ID: 26766490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.